AI In Healthcare Gamut – WHO Considers Adding Regulations

187

World Health Organisation has recently gone on to release a novel document that goes on to highlight the key regulatory considerations when it comes to the usage of AI in the gamut of healthcare. The report puts forth the value of making sure the security and efficient operation of AI systems.

WHO acknowledges the probable benefits when it comes to AI in enhancing health outcomes. However, it also brings about concerns that AI systems often get executed in a hasty way without an in-depth understanding when it comes to performance.

Therefore, this has the capacity to be either beneficial or harmful to the end users, which include healthcare professionals as well as patients.

Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, states that AI happens to have tremendous potential in enhancing healthcare. However, AI also presents significant challenges ranging from illegal data accumulation, dangers to cybersecurity, to ability to amplify biases or even spread misinformation. The purpose of this novel guidance is to help nations in successfully governing AI, and also let them take advantage of its potential in areas such as cancer treatment and also tuberculosis detection while also reducing the associated dangers that come along.

The publication goes on to identify six key areas for regulating AI in the field of healthcare:

  • Transparency and documentation: It is extremely pivotal to extensively document the whole product lifecycle and at the same time also keep a track of development processes.
  • Risk management: It is significant to deal with various problems such as intended use, continuous learning, human interventions as well as training models, and cybersecurity threats in a broad manner and make these models as much seamless as possible.
  • Validating data as well as being unambiguous about the usage of AI helps ensure safety as well as facilitate regulation.
  • Data quality:  Carefully evaluating systems pre-release is mandatory to guaranteeing systems do not cause surge in biases as well as errors.
  • Address the challenges put forth by significant and intricate regulations by placing a robust emphasis on comprehending the extent of jurisdiction as well as the requirements for consent. One such example is the General Data Protection Regulation- GDPR in Europe.

Partnership when it comes to regulators, patients, healthcare providers, industry representatives, as well as government partners is very significant. This can help ensure that products and services remain in line with regulations across their entire lifespan.

The ultimate aim of the new publication is to also offer a clear outline of the essential principles that governments as well as regulatory authorities can adhere to. This will help them in developing new guidelines and also modifying current ones on AI when it comes to national or regional levels.